Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NBY

NovaBay Pharmaceuticals (NBY)

NovaBay Pharmaceuticals Inc New
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:NBY
DateTimeSourceHeadlineSymbolCompany
03/07/20257:08AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
03/07/20257:07AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
02/18/20255:25PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:NBYNovaBay Pharmaceuticals Inc New
02/06/20256:30PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
02/04/20254:58PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
02/04/20254:58PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
01/23/20258:13AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
01/23/20258:12AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
01/23/20258:00AMBusiness WireNovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution ProposalAMEX:NBYNovaBay Pharmaceuticals Inc New
01/22/20254:27PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
01/10/20256:06PMEdgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:NBYNovaBay Pharmaceuticals Inc New
01/10/20257:03AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
12/19/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
12/19/20246:50AMBusiness WireNovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of StockholdersAMEX:NBYNovaBay Pharmaceuticals Inc New
12/11/20244:12PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
12/09/20247:05AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
12/09/20246:50AMBusiness WireNovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special MeetingAMEX:NBYNovaBay Pharmaceuticals Inc New
11/26/20244:08PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
11/22/20244:27PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
11/22/20244:05PMBusiness WireNovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
11/15/20248:10AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
11/15/20248:00AMBusiness WireProminent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova BrandAMEX:NBYNovaBay Pharmaceuticals Inc New
11/13/20245:15PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
11/12/20244:52PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
11/12/20246:01AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
11/08/20245:31PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
11/07/20244:13PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
11/07/20244:05PMBusiness WireNovaBay Pharmaceuticals Reports Third Quarter 2024 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
11/06/20244:58PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
11/06/20244:46PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
 Showing the most relevant articles for your search:AMEX:NBY